Prevention of Transmission of Virus Infections by Blood Transfusions and Removal of Virus Infectivity from Clotting Factor Concentrates
作者： R. J. Gerety
DOI: 10.1007/978-1-4613-2631-1_18
关键词: Hepatitis A 、 Virus 、 Hepatitis B virus 、 Viremia 、 Transmission (medicine) 、 Virology 、 Hepatitis 、 Hepatitis B 、 Clotting factor 、 Medicine
摘要: Virus infections are serious complications following blood transfusions or intravenous therapy with clotting factor concentrates. Hepatitis A virus (HAV) is rarely transmitted by and never plasma derivatives. characterized a short viremia which most often coincides clinical illness. In addition neutralizing antibodies to HAV present in all pools from concentrates manufactured (1). Chronic B non-A non-B hepatitis commonly follow acute (5 10% for B, more than 40% perhaps close 100% hepatitis). (HBV) serum levels of infectious up 108/ml (infectious units) while generally the range 102/ml (2,3). Little has been published concerning HTLV III plasma.
springer.com
sci-hub.st 参考文章(13)
J L Dienstag, R H Purcell, H J Alter, Non-A, non-B hepatitis. Yale Journal of Biology and Medicine. ,vol. 49, pp. 243- 250 ,(1976)
Harvey J. Alter, Wolf Szmuness, James E. Maynard, Viral hepatitis : 1981 international symposium Franklin Institute Press. ,(1982)
Edward Tabor, DavidL. Aronson, RobertJ. Gerety, REMOVAL OF HEPATITIS-B-VIRUS INFECTIVITY FROM FACTOR-IX COMPLEX BY HEPATITIS-B IMMUNE-GLOBULIN: Experiments in Chimpanzees The Lancet. ,vol. 316, pp. 68- 70 ,(1980) , 10.1016/S0140-6736(80)92942-6
C. Trepo, O. Hantz, M. F. Jacquier, G. Nemoz, R. Cappel, D. Trepo, Different Fates of Hepatitis B Virus Markers during Plasma Fractionation Vox Sanguinis. ,vol. 35, pp. 143- 148 ,(1978) , 10.1111/J.1423-0410.1978.TB02913.X
Sydney S. Gellis, John R. Neefe, Joseph Stokes, Lawrence E. Strong, Charles A. Janeway, George Scatchard, CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXVI. INACTIVATION OF THE VIRUS OF HOMOLOGOUS SERUM HEPATITIS IN SOLUTIONS OF NORMAL HUMAN SERUM ALBUMIN BY MEANS OF HEAT 12 Journal of Clinical Investigation. ,vol. 27, pp. 239- 244 ,(1948) , 10.1172/JCI101939
L.A. Smallwood, E. Tabor, J.S. Finlayson, R.J. Gerety, Antibodies to hepatitis A virus in immune serum globulin. The Lancet. ,vol. 316, pp. 482- 483 ,(1980) , 10.1016/S0140-6736(80)91921-2
Belinda Seto, Sten Iwarson, WilliamG. Coleman, RobertJ. Gerety, Detection of reverse transcriptase activity in association with the non-A, non-B hepatitis agent(s). The Lancet. ,vol. 324, pp. 941- 943 ,(1984) , 10.1016/S0140-6736(84)91163-2
Jean-Pierre Soulier, Prevention of Virus B Hepatitis (SH Hepatitis) Archives of Pediatrics & Adolescent Medicine. ,vol. 123, pp. 429- 434 ,(1972) , 10.1001/ARCHPEDI.1972.02110100161061
Edward Tabor, Genesio Murano, Philip Snoy, Robert J. Gerety, Inactivation of hepatitis B virus by heat in antithrombin III stabilized with citrate Thrombosis Research. ,vol. 22, pp. 233- 238 ,(1981) , 10.1016/0049-3848(81)90326-1
L. F. Barker, J. E. Maynard, R. H. Purcell, J. H. Hoofnagle, K. R. Berquist, W. T. London, R. J. Gerety, D. H. Krushak, Hepatitis B Virus Infection in Chimpanzees: Titration of Subtypes The Journal of Infectious Diseases. ,vol. 132, pp. 451- 458 ,(1975) , 10.1093/INFDIS/132.4.451